Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03753919 |
|---|---|
| Brief Title: | Durvalumab Plus Tremelimumab for the Treatment of Patients With Progressive, Refractory Advanced Thyroid Carcinoma -The DUTHY Trial (DUTHY) |
| First Submitted : | November 20, 2018 |
| First Submitted that Met QC Criteria : | November 22, 2018 |
| First Posted : | November 27, 2018 |
| Last Update Submitted that Met QC Criteria : | November 10, 2023 |
| Last Update Posted : | November 13, 2023 |